Plasmid DNA manufacturing services refer to specialized processes offered by biotechnology companies to produce plasmid DNA at various scales and quantities. Plasmid DNA is a small, circular piece of DNA commonly used in biotechnology and genetic engineering applications, such as gene therapy, genetic research, vaccine development, and recombinant protein production.
The global Plasmid DNA Manufacturing Services market is projected to reach US$ 3106.6 million in 2029, increasing from US$ 1297.3 million in 2022, with the CAGR of 12.8% during the period of 2023 to 2029.
The development and commercialization of gene editing technologies like CRISPR-Cas have increased the demand for high-quality plasmid DNA as essential tools for gene editing research and applications.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Plasmid DNA Manufacturing Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Vigene Biosciences
Aldevron
Creative Biogene
Thermo Fisher Scientific Inc.
Kaneka Eurogentec SA
AGC Biologics
Andelyn Biosciences
Biomay
VGXI, Inc.
VectorBuilder
Xpress Biologics
Biovian
WuXi Advanced Therapies
Catalent, Inc
Charles River Laboratories
Esco Aster Pte. Ltd
Waisman
Boehringer Ingelheim Biopharmaceuticals GmbH
Segment by Type
Research-Grade Plasmids
High Quality (HQ) / GMP-Ready™ Plasmids
CGMP Plasmid
Others
Segment by Application
Medical Industry
Biological Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Plasmid DNA Manufacturing Services report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid DNA Manufacturing Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Research-Grade Plasmids
1.2.3 High Quality (HQ) / GMP-Ready™ Plasmids
1.2.4 CGMP Plasmid
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasmid DNA Manufacturing Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Medical Industry
1.3.3 Biological Industry
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasmid DNA Manufacturing Services Market Perspective (2018-2029)
2.2 Plasmid DNA Manufacturing Services Growth Trends by Region
2.2.1 Global Plasmid DNA Manufacturing Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Plasmid DNA Manufacturing Services Historic Market Size by Region (2018-2023)
2.2.3 Plasmid DNA Manufacturing Services Forecasted Market Size by Region (2024-2029)
2.3 Plasmid DNA Manufacturing Services Market Dynamics
2.3.1 Plasmid DNA Manufacturing Services Industry Trends
2.3.2 Plasmid DNA Manufacturing Services Market Drivers
2.3.3 Plasmid DNA Manufacturing Services Market Challenges
2.3.4 Plasmid DNA Manufacturing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid DNA Manufacturing Services Players by Revenue
3.1.1 Global Top Plasmid DNA Manufacturing Services Players by Revenue (2018-2023)
3.1.2 Global Plasmid DNA Manufacturing Services Revenue Market Share by Players (2018-2023)
3.2 Global Plasmid DNA Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasmid DNA Manufacturing Services Revenue
3.4 Global Plasmid DNA Manufacturing Services Market Concentration Ratio
3.4.1 Global Plasmid DNA Manufacturing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid DNA Manufacturing Services Revenue in 2022
3.5 Plasmid DNA Manufacturing Services Key Players Head office and Area Served
3.6 Key Players Plasmid DNA Manufacturing Services Product Solution and Service
3.7 Date of Enter into Plasmid DNA Manufacturing Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid DNA Manufacturing Services Breakdown Data by Type
4.1 Global Plasmid DNA Manufacturing Services Historic Market Size by Type (2018-2023)
4.2 Global Plasmid DNA Manufacturing Services Forecasted Market Size by Type (2024-2029)
5 Plasmid DNA Manufacturing Services Breakdown Data by Application
5.1 Global Plasmid DNA Manufacturing Services Historic Market Size by Application (2018-2023)
5.2 Global Plasmid DNA Manufacturing Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Plasmid DNA Manufacturing Services Market Size (2018-2029)
6.2 North America Plasmid DNA Manufacturing Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Plasmid DNA Manufacturing Services Market Size by Country (2018-2023)
6.4 North America Plasmid DNA Manufacturing Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasmid DNA Manufacturing Services Market Size (2018-2029)
7.2 Europe Plasmid DNA Manufacturing Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Plasmid DNA Manufacturing Services Market Size by Country (2018-2023)
7.4 Europe Plasmid DNA Manufacturing Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid DNA Manufacturing Services Market Size (2018-2029)
8.2 Asia-Pacific Plasmid DNA Manufacturing Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Plasmid DNA Manufacturing Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Plasmid DNA Manufacturing Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasmid DNA Manufacturing Services Market Size (2018-2029)
9.2 Latin America Plasmid DNA Manufacturing Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Plasmid DNA Manufacturing Services Market Size by Country (2018-2023)
9.4 Latin America Plasmid DNA Manufacturing Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid DNA Manufacturing Services Market Size (2018-2029)
10.2 Middle East & Africa Plasmid DNA Manufacturing Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Plasmid DNA Manufacturing Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Plasmid DNA Manufacturing Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Vigene Biosciences
11.1.1 Vigene Biosciences Company Detail
11.1.2 Vigene Biosciences Business Overview
11.1.3 Vigene Biosciences Plasmid DNA Manufacturing Services Introduction
11.1.4 Vigene Biosciences Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.1.5 Vigene Biosciences Recent Development
11.2 Aldevron
11.2.1 Aldevron Company Detail
11.2.2 Aldevron Business Overview
11.2.3 Aldevron Plasmid DNA Manufacturing Services Introduction
11.2.4 Aldevron Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.2.5 Aldevron Recent Development
11.3 Creative Biogene
11.3.1 Creative Biogene Company Detail
11.3.2 Creative Biogene Business Overview
11.3.3 Creative Biogene Plasmid DNA Manufacturing Services Introduction
11.3.4 Creative Biogene Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.3.5 Creative Biogene Recent Development
11.4 Thermo Fisher Scientific Inc.
11.4.1 Thermo Fisher Scientific Inc. Company Detail
11.4.2 Thermo Fisher Scientific Inc. Business Overview
11.4.3 Thermo Fisher Scientific Inc. Plasmid DNA Manufacturing Services Introduction
11.4.4 Thermo Fisher Scientific Inc. Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.4.5 Thermo Fisher Scientific Inc. Recent Development
11.5 Kaneka Eurogentec SA
11.5.1 Kaneka Eurogentec SA Company Detail
11.5.2 Kaneka Eurogentec SA Business Overview
11.5.3 Kaneka Eurogentec SA Plasmid DNA Manufacturing Services Introduction
11.5.4 Kaneka Eurogentec SA Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.5.5 Kaneka Eurogentec SA Recent Development
11.6 AGC Biologics
11.6.1 AGC Biologics Company Detail
11.6.2 AGC Biologics Business Overview
11.6.3 AGC Biologics Plasmid DNA Manufacturing Services Introduction
11.6.4 AGC Biologics Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.6.5 AGC Biologics Recent Development
11.7 Andelyn Biosciences
11.7.1 Andelyn Biosciences Company Detail
11.7.2 Andelyn Biosciences Business Overview
11.7.3 Andelyn Biosciences Plasmid DNA Manufacturing Services Introduction
11.7.4 Andelyn Biosciences Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.7.5 Andelyn Biosciences Recent Development
11.8 Biomay
11.8.1 Biomay Company Detail
11.8.2 Biomay Business Overview
11.8.3 Biomay Plasmid DNA Manufacturing Services Introduction
11.8.4 Biomay Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.8.5 Biomay Recent Development
11.9 VGXI, Inc.
11.9.1 VGXI, Inc. Company Detail
11.9.2 VGXI, Inc. Business Overview
11.9.3 VGXI, Inc. Plasmid DNA Manufacturing Services Introduction
11.9.4 VGXI, Inc. Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.9.5 VGXI, Inc. Recent Development
11.10 VectorBuilder
11.10.1 VectorBuilder Company Detail
11.10.2 VectorBuilder Business Overview
11.10.3 VectorBuilder Plasmid DNA Manufacturing Services Introduction
11.10.4 VectorBuilder Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.10.5 VectorBuilder Recent Development
11.11 Xpress Biologics
11.11.1 Xpress Biologics Company Detail
11.11.2 Xpress Biologics Business Overview
11.11.3 Xpress Biologics Plasmid DNA Manufacturing Services Introduction
11.11.4 Xpress Biologics Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.11.5 Xpress Biologics Recent Development
11.12 Biovian
11.12.1 Biovian Company Detail
11.12.2 Biovian Business Overview
11.12.3 Biovian Plasmid DNA Manufacturing Services Introduction
11.12.4 Biovian Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.12.5 Biovian Recent Development
11.13 WuXi Advanced Therapies
11.13.1 WuXi Advanced Therapies Company Detail
11.13.2 WuXi Advanced Therapies Business Overview
11.13.3 WuXi Advanced Therapies Plasmid DNA Manufacturing Services Introduction
11.13.4 WuXi Advanced Therapies Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.13.5 WuXi Advanced Therapies Recent Development
11.14 Catalent, Inc
11.14.1 Catalent, Inc Company Detail
11.14.2 Catalent, Inc Business Overview
11.14.3 Catalent, Inc Plasmid DNA Manufacturing Services Introduction
11.14.4 Catalent, Inc Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.14.5 Catalent, Inc Recent Development
11.15 Charles River Laboratories
11.15.1 Charles River Laboratories Company Detail
11.15.2 Charles River Laboratories Business Overview
11.15.3 Charles River Laboratories Plasmid DNA Manufacturing Services Introduction
11.15.4 Charles River Laboratories Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.15.5 Charles River Laboratories Recent Development
11.16 Esco Aster Pte. Ltd
11.16.1 Esco Aster Pte. Ltd Company Detail
11.16.2 Esco Aster Pte. Ltd Business Overview
11.16.3 Esco Aster Pte. Ltd Plasmid DNA Manufacturing Services Introduction
11.16.4 Esco Aster Pte. Ltd Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.16.5 Esco Aster Pte. Ltd Recent Development
11.17 Waisman
11.17.1 Waisman Company Detail
11.17.2 Waisman Business Overview
11.17.3 Waisman Plasmid DNA Manufacturing Services Introduction
11.17.4 Waisman Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.17.5 Waisman Recent Development
11.18 Boehringer Ingelheim Biopharmaceuticals GmbH
11.18.1 Boehringer Ingelheim Biopharmaceuticals GmbH Company Detail
11.18.2 Boehringer Ingelheim Biopharmaceuticals GmbH Business Overview
11.18.3 Boehringer Ingelheim Biopharmaceuticals GmbH Plasmid DNA Manufacturing Services Introduction
11.18.4 Boehringer Ingelheim Biopharmaceuticals GmbH Revenue in Plasmid DNA Manufacturing Services Business (2018-2023)
11.18.5 Boehringer Ingelheim Biopharmaceuticals GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Vigene Biosciences
Aldevron
Creative Biogene
Thermo Fisher Scientific Inc.
Kaneka Eurogentec SA
AGC Biologics
Andelyn Biosciences
Biomay
VGXI, Inc.
VectorBuilder
Xpress Biologics
Biovian
WuXi Advanced Therapies
Catalent, Inc
Charles River Laboratories
Esco Aster Pte. Ltd
Waisman
Boehringer Ingelheim Biopharmaceuticals GmbH
*If Applicable.